Article

Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification

2021-05-28

Abstract excerpt

<title>Abstract</title> Despite the extensive study of <italic>MYCN</italic>-amplified neuroblastomas, there is a significant unmet clinical need in <italic>MYCN</italic> non-amplified neuroblastomas. In particular, the extent of heterogeneity within the <italic>MYCN</italic> non-amplified population is unknown. Here, we investigate whether transcriptional subtyping of <italic>MYCN</italic> non-amplified neuro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9c9c0776-c8d8-5d67-98a7-7cc80e2b1e55
DOI: 10.21203/rs.3.rs-478917/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratificationDOI 10.21203/rs.3.rs-478917/v1Read

Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratificationSemantic proximity Read

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastomaSemantic proximity Read

Bioinformatic analysis of the inner heterogeneity within MYCN non-amplified pediatric neuroblastoma sub-groupSemantic proximity Read

MYCN in Neuroblastoma: “Old Wine into New Wineskins”Semantic proximity Read

The MYCN Enigma: Significance of MYCN Expression in NeuroblastomaSemantic proximity Read

Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN -Not-Amplified Human NeuroblastomaSemantic proximity Read

High-risk, Expression-Based Prognostic Long Noncoding RNA Signature in NeuroblastomaSemantic proximity Read

The neuroblastoma tumor microenvironment: From an in-depth characterization towards novel therapiesSemantic proximity Read

Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastomaSemantic proximity Read

The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic ApproachesSemantic proximity Read

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma.Semantic proximity Read

High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastomaSemantic proximity Read